Please login to the form below
Pharmaceutical Market Europe (PME)
PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.
From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.
PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.
FDA starts review of Sanofi’s oral type 1 diabetes drug
FDA clears Dova drug for liver-related low blood platelets
Drug is in the same class as Novartis’ Promacta/Revolade
More encouraging data for Spark and Pfizer’s potential haemophilia B cure
Pfizer set to commence phase III trials
Positive mid-stage trial gives Allergy’s investors some welcome relief
Its grass pollen vaccine showed a “highly significant” dose response
Articles
-
We can be heroes -
What does ‘digital’ look like for global pharma Learning & Development? -
The NHS and ABPI at 70: inching closer to the triple winThe NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value
-
Getting the sizing rightMerger and Acquisition activity in our sector can learn from the natural world
-
Data visualisation in medical communications
Pharmaceutical Market Europe - May 2018
We start off looking at the newly released 2018 edition of the Drugs to Watch Report, with 12 blockbusters predicted to launch this year. There is hope that some of these new drugs may help patients who are dealing with several of the most unmanageable diseases.
Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app
Editor - Iona Everson
Have your say...
Subscribe
'Nothing about us without us'
Why patient engagement is essential throughout the entire product life cycle
Getting the sizing right
Merger and Acquisition activity in our sector can learn from the natural world
Featured jobs
- Medical Writer - Medical Communications
-
£30, 000 - £40, 000 according to skills and experience plus benefits
-
Scientific Engagement Director
-
Salary will be dependant on experience
-
Scientific Director
-
Great salary and bebefits
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
-
Director – Healthcare PR
-
Salary TBC
-
Associate Director, Healthcare PR
-
£60, 000 – £67, 000+ benefits
- Assistant Product Manager - Hertfordshire
-
Competitive salary depending on experience benefits
- Senior Account Director or Business Unit Director, Healthcare Ad...
-
C£60, 000 – £70, 000 benefits
-
Product Manager - Hertfordshire
-
Competitive salary depending on experience benefits
- Sales & Marketing Manager - New Launch - Mental Health - S E...
-
Highly Competitive Basic, Bonus &Benefits
-
Senior Medical Writer
-
Great salary and bebefits
- CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...
-
EXCELLENT DAY RATES AVAILABLE
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Senior Account Manager / Account Director
-
Great salary and bebefits
Subscribe to our email news alerts
- Novo Nordisk expands cell therapy R&D, says type 1 diabetes cure a step closer
- Immuno-oncology at ASCO: survival data, combinations and new indications
- Novartis, Amgen set low price for first CGRP migraine drug
- Moving annual total (MAT)
- Key success factor (KSF)
- Janssen named ‘Pharma Company of the Year’ at business intelligence awards
- We can be heroes
- What does ‘digital’ look like for global pharma Learning & Development?
- FDA starts review of Sanofi’s oral type 1 diabetes drug
- Is the pharma business model ready for precision medicine?
- Porterhouse Medical announces another well-deserved promotion within the group
- FDA clears Dova drug for liver-related low blood platelets
PMHub
Market Access Transformation
Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...
Latest intelligence
- Is the pharma business model ready for precision medicine?
- Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
- The NHS and ABPI at 70: inching closer to the triple win
- The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
- What pharma marketers can learn from behavioural science
- Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....
Quick links
Infographics
